Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia
- 1 January 1995
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 54 (1) , 59-60
- https://doi.org/10.1111/j.1600-0609.1995.tb01630.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Multiple thrombosis in acute promyelocytic leukaemia after tretinoinThe Lancet, 1993
- All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesBlood, 1992
- Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- All-trans retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia [letter; comment]Blood, 1992
- Low molecular weight heparinBlood, 1992
- A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patientsBlood, 1991
- Prevention of Deep Vein Thrombosis after Elective Hip SurgeryAnnals of Internal Medicine, 1991
- Treatment of Acute Promyelocytic Leukemia: A Report of 70 CasesLeukemia & Lymphoma, 1991
- Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients [see comments]Blood, 1990
- Beneficial effect of heparin in the management of patients with APLBritish Journal of Haematology, 1988